Moderna, Inc. (NASDAQ:MRNA)

BRIEF

published on 11/25/2024 at 13:05, 26 days 5 hours ago

Moderna to Present at December 2024 Investor Conferences

Investor Conferences Healthcare Webcast MRNA Technology Moderna
PRESS RELEASE

published on 11/25/2024 at 13:00, 26 days 5 hours ago

Moderna to Present at Upcoming Conferences in December 2024
Moderna, Inc. announces participation in investor conferences and highlights mRNA technology advancements. Company overview and contact info provided

Investor Conferences Healthcare MRNA Technology Moderna Vaccines
BRIEF

published on 11/12/2024 at 14:20, 1 month 9 days ago

Moderna Tops BioSpace's Best Places to Work for Fourth Year

Innovation AI Integration Life Sciences Moderna Workplace Ranking
PRESS RELEASE

published on 11/12/2024 at 14:15, 1 month 9 days ago

Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year
Moderna, Inc. named top large employer in BioSpace's 2025 Best Places to Work report for fourth consecutive year. Company's commitment to innovation recognized

Innovation Best Places To Work Moderna Employee Recognition BioSpace
BRIEF

published on 11/08/2024 at 13:35, 1 month 13 days ago

Moderna Secures Health Canada Approval for RSV Vaccine for Seniors

Health Canada MRNA Technology Moderna RSV Vaccine MRESVIA
PRESS RELEASE

published on 11/08/2024 at 13:30, 1 month 13 days ago

Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
Health Canada approves Moderna's mRESVIA, a single-dose mRNA vaccine against RSV for adults aged 60 and older in a convenient pre-filled syringe. The vaccine's approval follows successful Phase 3 trial ConquerRSV

Health Canada MRNA Technology Moderna RSV Vaccine MRESVIA
BRIEF

published on 11/07/2024 at 12:35, 1 month 14 days ago

Moderna Reveals Third Quarter 2024 Financial Performance Alongside Strategic Developments

Financial Results Moderna Product Sales MRNA Vaccines Executive Expansion
PRESS RELEASE

published on 11/07/2024 at 12:30, 1 month 14 days ago

Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q3 revenue of $1.9B, net income of $13M, and EPS of $0.03. Initiates Phase 3 trials for mRNA vaccines, reiterates 2024 sales guidance. Announces expansion of Executive Committee

Revenue Executive Committee Moderna Vaccines Q3
BRIEF

published on 10/31/2024 at 12:05, 1 month 21 days ago

Moderna to Participate in November 2024 Investor Conferences

Investor Conferences Healthcare Innovation MRNA Technology Moderna Webcast Access
PRESS RELEASE

published on 10/31/2024 at 12:00, 1 month 21 days ago

Moderna to Present at Upcoming Conferences in November 2024
Moderna, Inc. to participate in upcoming investor conferences: Guggenheim's Healthcare Innovation Conference, UBS Global Healthcare Conference, Jefferies London Healthcare Conference. Moderna leading in mRNA medicine technology for disease treatment and prevention

Investor Conferences Healthcare Innovation MRNA Medicine Moderna Disease Treatment

Published on 12/21/2024 at 01:30, 17 hours 24 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 24 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 49 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 18 hours 54 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 24 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 18 hours 2 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 9 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 43 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 23 hours 58 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 36 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 4 hours ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News